Epidermal Growth Factor-Like Domain Multiple 7 (EGFL7): Expression and Possible Effect on Biliary Epithelium Growth in Cholangiocarcinoma

European Journal of Histochemistry - Italy
doi 10.4081/ejh.2018.2971
Full Text
Abstract

Available in full text

Date
Authors
Publisher

PAGEPress Publications

Related search

Epidermal Growth Factor-Like Domain 7 Is a Marker of the Endothelial Lineage and Active Angiogenesis

Genesis
MedicineEndocrinologyGeneticsCell Biology
2014English

Lysophosphatidylcholine Increases Expression of Heparin-Binding Epidermal Growth Factor Like Growth Factor in Human T Lymphocytes

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
1997English

Epidermal Growth Factor Receptor (EGFR) in Biliary Tract Cancer

HPB
HepatologyGastroenterology
2016English

Epidermal Growth Factor Receptor and Human Epidermal Growth Receptor 2 Expression in Parotid Mucoepidermoid Carcinoma: Possible Implications for Targeted Therapy

Oncology Reports
MedicineCancer ResearchOncology
2008English

453 Effect of Growth Hormone on Epidermal Growth Factor Excretion

Pediatric Research
Child HealthPediatricsPerinatology
1985English

Epidermal Growth Factor Receptor Activation by Epidermal Growth Factor Mediates Oxidant-Induced Goblet Cell Metaplasia in Human Airway Epithelium

American Journal of Respiratory Cell and Molecular Biology
Respiratory MedicinePulmonaryClinical BiochemistryCell BiologyMolecular Biology
2006English

Suppression of the Biological Activities of the Epidermal Growth Factor (EGF)-like Domain by the Heparin-Binding Domain of Heparin-Binding EGF-like Growth Factor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2004English

Clinical Significance of Heparin-Binding Epidermal Growth Factor-Like Growth Factor and a Disintegrin and Metalloprotease 17 Expression in Human Ovarian Cancer

Clinical Cancer Research
Cancer ResearchOncology
2005English

Impact of Epidermal Growth Factor Receptor Gene Expression Level on Clinical Outcomes in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma Patients Taking First-Line Epidermal Growth Factor Receptor–tyrosine Kinase Inhibitors

Tumor Biology
MedicineCancer Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy